Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $732,967 | 326 | 80.1% |
| Travel and Lodging | $122,533 | 253 | 13.4% |
| Food and Beverage | $25,827 | 362 | 2.8% |
| Consulting Fee | $17,093 | 6 | 1.9% |
| Honoraria | $16,109 | 2 | 1.8% |
| Education | $92.28 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $331,296 | 298 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $307,370 | 362 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $180,882 | 173 | $0 (2021) |
| Takeda Pharmaceuticals America, Inc. | $26,572 | 19 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $20,877 | 21 | $0 (2024) |
| ITI, Inc. | $15,561 | 17 | $0 (2022) |
| H. Lundbeck A S | $15,021 | 4 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $12,551 | 14 | $0 (2019) |
| Lundbeck LLC | $3,661 | 14 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $745.88 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $56,928 | 61 | Alkermes, Inc. ($24,213) |
| 2023 | $55,474 | 50 | Alkermes, Inc. ($42,929) |
| 2022 | $55,849 | 64 | Alkermes, Inc. ($35,937) |
| 2021 | $57,672 | 60 | Alkermes, Inc. ($37,228) |
| 2020 | $48,018 | 51 | Alkermes, Inc. ($28,264) |
| 2019 | $147,900 | 150 | Alkermes, Inc. ($65,721) |
| 2018 | $214,124 | 233 | Sunovion Pharmaceuticals Inc. ($92,943) |
| 2017 | $278,655 | 285 | Otsuka America Pharmaceutical, Inc. ($104,722) |
All Payment Transactions
954 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,840.00 | General |
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,300.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,116.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,840.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: CNS | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $41.04 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $114.87 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.71 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,300.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $122.44 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/28/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,548.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: CNS | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $6,440.00 | General |
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $460.00 | General |
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,548.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,548.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $346.52 | General |
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $226.86 | General |
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $58.33 | General |
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $49.75 | General |
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $49.75 | General |
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $29.86 | General |
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $29.86 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 619 | 2,728 | $427,600 | $194,783 |
| 2022 | 4 | 713 | 3,120 | $489,600 | $202,278 |
| 2021 | 4 | 561 | 2,539 | $413,550 | $166,104 |
| 2020 | 4 | 410 | 1,811 | $311,250 | $115,613 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 173 | 1,822 | $273,300 | $130,536 | 47.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 167 | 184 | $46,000 | $26,238 | 57.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 118 | 547 | $82,050 | $25,102 | 30.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 161 | 175 | $26,250 | $12,907 | 49.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 207 | 2,035 | $305,250 | $132,795 | 43.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 199 | 216 | $54,000 | $31,793 | 58.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 113 | 659 | $98,850 | $23,837 | 24.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 194 | 210 | $31,500 | $13,854 | 44.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 164 | 1,625 | $243,750 | $109,481 | 44.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 149 | 163 | $45,800 | $24,863 | 54.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 104 | 596 | $100,750 | $21,210 | 21.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 144 | 155 | $23,250 | $10,549 | 45.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 117 | 1,150 | $172,500 | $77,207 | 44.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 73 | 426 | $85,200 | $15,801 | 18.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 115 | 122 | $36,600 | $14,840 | 40.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 105 | 113 | $16,950 | $7,765 | 45.8% |
About Dr. Abid Khan, MD
Dr. Abid Khan, MD is a Psychiatry healthcare provider based in Amityville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1932288735.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abid Khan, MD has received a total of $914,621 in payments from pharmaceutical and medical device companies, with $56,928 received in 2024. These payments were reported across 954 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($732,967).
As a Medicare-enrolled provider, Khan has provided services to 2,303 Medicare beneficiaries, totaling 10,198 services with total Medicare billing of $678,778. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Amityville, NY
- Active Since 11/03/2006
- Last Updated 04/10/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1932288735
Products in Payments
- LATUDA (Drug) $180,882
- ABILIFY MAINTENA (Drug) $159,995
- REXULTI (Drug) $158,814
- ARISTADA (Drug) $153,025
- Aristada 441 mg (Drug) $96,935
- LYBALVI (Drug) $81,244
- Trintellix (Drug) $38,926
- CAPLYTA (Drug) $15,561
- COBENFY (Drug) $11,221
- ABILIFY ASIMTUFII (Drug) $3,779
- INVEGA SUSTENNA (Drug) $554.28
- Entyvio (Biological) $196.20
- SPRAVATO (Drug) $149.95
- Vivitrol 380 mg (Drug) $68.50
- INGREZZA (Drug) $67.17
- INVEGA TRINZA (Drug) $32.55
- VIVITROL (Drug) $23.69
- AUSTEDO (Drug) $17.20
- INVEGA (Drug) $9.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Amityville
Dr. Faisal Rafiq, M.d, M.D
Psychiatry — Payments: $106,745
Won Gi Im, Md, MD
Psychiatry — Payments: $22,054
Kwang Lee, Md, MD
Psychiatry — Payments: $16,053
Martin Calton, Md, MD
Psychiatry — Payments: $5,942
Dr. Edward Sodaro, Md, MD
Psychiatry — Payments: $2,137
Ejike Onuogu, Md, MD
Psychiatry — Payments: $2,100